RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eton Pharmaceuticals Stock

Eton Pharmaceuticals P/S 2024

Eton Pharmaceuticals P/S

2.46

Ticker

ETON

ISIN

US29772L1089

WKN

A2N38G

As of Oct 6, 2024, Eton Pharmaceuticals's P/S ratio stood at 2.46, a -22.15% change from the 3.16 P/S ratio recorded in the previous year.

The Eton Pharmaceuticals P/S history

Eton Pharmaceuticals Aktienanalyse

What does Eton Pharmaceuticals do?

The company Eton Pharmaceuticals Inc is an innovative company that specializes in the development of high-quality and reliable medications. The company was founded in 2017 in Deer Park, Illinois, and has since become a leading company in the pharmaceutical industry. Eton Pharmaceuticals Inc's business model is closely related to the development of new medications. The company specializes in the development of so-called "gel-coated" medications, which have better efficacy and tolerability than conventional medications. The company uses innovative and patented technologies to overcome the current limitations of medications and provide customers with the best possible treatment. Eton Pharmaceuticals Inc has different divisions for the development of medications. One of the most important divisions is oncology, where medications for tumor treatment are developed. The company relies on innovative approaches to discover new active substances and improve the treatment of cancer patients. In addition, the company has extensive experience in the production of antibiotics. Eton Pharmaceuticals Inc has developed its own products tailored to the needs of patients, promising fast and effective effects. The company has also developed special medications for the treatment of cardiovascular diseases, aiming to provide patients with a better quality of life. One of the products offered by Eton Pharmaceuticals Inc is the medication "BML-190". This medication is an anti-inflammatory drug used for pain and inflammation. Its special feature is its high effectiveness with minimal side effects, which often occur with other medications. Another product of Eton Pharmaceuticals Inc is the medication "DS-300", used for certain eye diseases. The medication contains an active substance that acts on the eyes and allows for quick healing. Thanks to the innovative technology used in its development, this medication is well tolerated and has minimal side effects. Overall, Eton Pharmaceuticals Inc is an innovative company specializing in the development of high-quality medications. With its business model and expertise in various areas of the pharmaceutical industry, the company is well equipped to continue making significant contributions to healthcare. Eton Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Eton Pharmaceuticals's P/S Ratio

Eton Pharmaceuticals's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Eton Pharmaceuticals's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Eton Pharmaceuticals's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Eton Pharmaceuticals’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Eton Pharmaceuticals stock

What is the price-to-earnings ratio of Eton Pharmaceuticals?

The price-earnings ratio of Eton Pharmaceuticals is currently 2.46.

How has the price-earnings ratio of Eton Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Eton Pharmaceuticals has increased by -22.15% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Eton Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Eton Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Eton Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Eton Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Eton Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Eton Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Eton Pharmaceuticals?

Some factors that influence the price-earnings ratio of Eton Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Eton Pharmaceuticals pay?

Over the past 12 months, Eton Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eton Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Eton Pharmaceuticals?

The current dividend yield of Eton Pharmaceuticals is .

When does Eton Pharmaceuticals pay dividends?

Eton Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eton Pharmaceuticals?

Eton Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Eton Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eton Pharmaceuticals located?

Eton Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eton Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eton Pharmaceuticals from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did Eton Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of Eton Pharmaceuticals in the year 2023?

In the year 2023, Eton Pharmaceuticals distributed 0 USD as dividends.

In which currency does Eton Pharmaceuticals pay out the dividend?

The dividends of Eton Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Eton Pharmaceuticals

Our stock analysis for Eton Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eton Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.